Reply to the Letter Regarding "Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study"

被引：0

作者：

Kudo, Masatoshi ^{[1
]}

Tsuchiya, Kaoru ^{[2
]}

Yamashita, Tatsuya ^{[3
]}

Koga, Hironori ^{[4
]}

Nakagawa, Yuki ^{[5
]}

Ikeda, Masafumi ^{[6
]}

机构：

[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan

[2] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan

[3] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Japan

[4] Kurume Univ Hosp, Dept Gastroenterol, Kurume, Japan

[5] Chugai Pharmaceut Ltd, Dept Biometr, Tokyo, Japan

[6] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Japan

来源：

LIVER CANCER | 2024年 / 13卷 / 06期

关键词：

Atezolizumab; Bevacizumab; Unresectable hepatocellular carcinoma; Adverse events of special interest; Skipped bevacizumab;

D O I：

10.1159/000539205

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：671 / 673

页数：3

共 4 条

[1] Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma [J].

Han, Ji Won ;

Jang, Jeong Won .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)

[2] Letter regarding "Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study" [J].

Hatanaka, Takeshi ;

Hiraoka, Atsushi ;

Tada, Toshifumi ;

Kakizaki, Satoru .

LIVER CANCER, 2024, 13 (06) :669-670

[3] Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis [J].

Hatanaka, Takeshi ;

Hiraoka, Atsushi ;

Tada, Toshifumi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Tsuji, Kunihiko ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Yasuda, Satoshi ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Tanaka, Takaaki ;

Ohama, Hideko ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Imai, Michitaka ;

Naganuma, Atsushi ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Joko, Kouji ;

Iijima, Hiroko ;

Hiasa, Yoichi ;

Kumada, Takashi .

HEPATOLOGY RESEARCH, 2022, 52 (05) :462-470

[4]

Kudo M., 2023, Liver Cancer, V2023, P1

← 1 →